Related Experiment Video
Updated: Jan 11, 2026
Bone Marrow Sampling and Transplants
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
F M Ruemmele1, S R Targan, G Levy
1Division of Gastroenterology-Nutrition, Department of Pediatrics, Ste-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
Insights
Accurate serological assays for anti-neutrophil cytoplasmic antibodies (ANCAs) and anti-Saccharomyces cerevisiae antibodies (ASCAs) aid in diagnosing pediatric inflammatory bowel disease (IBD). These tests show high specificity for Crohn's disease and ulcerative colitis, assisting in diagnosis and treatment decisions.
Area of Science:
- Pediatric gastroenterology
- Immunology
- Diagnostic assay development
Background:
- Accurate diagnosis of pediatric inflammatory bowel disease (IBD) subtypes, ulcerative colitis (UC) and Crohn's disease (CD), is crucial.
- Serological assays for perinuclear (p) antineutrophil cytoplasmic antibodies (ANCAs) and anti-Saccharomyces cerevisiae antibodies (ASCAs) show potential for IBD diagnosis.
Purpose of the Study:
- To evaluate the diagnostic accuracy of modified IgA and IgG anti-Saccharomyces cerevisiae antibody (ASCA) and perinuclear (p) antineutrophil cytoplasmic antibody (pANCA) assays in children with UC, CD, and non-IBD controls.
- To determine the utility of these serological markers in differentiating pediatric IBD subtypes.
Main Methods:
- Serum samples from pediatric patients with UC, CD, and without IBD were analyzed for IgA and IgG ASCA and pANCA using enzyme-linked immunosorbent assay.
- The perinuclear location of ANCAs was confirmed using indirect immunofluorescence and deoxyribonuclease treatment.
Main Results:
- IgA and IgG ASCA titers were significantly elevated and highly specific for Crohn's disease (95-100%).
- pANCA demonstrated 92% specificity for ulcerative colitis and was absent in non-IBD controls.
- Disease characteristics and immunosuppressive therapy did not affect ASCA or pANCA results; ASCA titers decreased postoperatively in CD patients, while pANCA remained positive in UC patients.
Conclusions:
- ASCA and pANCA assays exhibit high disease specificity for CD and UC, respectively, in pediatric patients.
- These serological tests can significantly assist clinicians in diagnosing and categorizing pediatric IBD.
- The assays may prove valuable in guiding therapeutic decisions for pediatric IBD.
Background & Aims:
Accurate serological assays are desirable for the diagnosis of inflammatory bowel disease (IBD) types in the pediatric age group. The aim of this study was to test the diagnostic accuracy of modified assays for perinuclear (p) antineutrophil cytoplasmic antibodies (ANCAs) and anti-Saccharomyces cerevisiae antibodies (ASCAs) in patients with pediatric ulcerative colitis (UC) and Crohn's disease (CD) and in those without IBD.
Methods:
With observers blinded to patients' diagnoses, serum specimens were analyzed for immunoglobulin (Ig) A and IgG ASCAs and ANCAs by enzyme-linked immunosorbent assay. The perinuclear location of ANCAs visualized by indirect immunofluorescence was confirmed by its disappearance after administration of deoxyribonuclease.
Results:
IgA and IgG ASCA titers were significantly greater and highly specific for CD (95% for either, 100% if both positive). pANCA was 92% specific for UC and absent in all non-IBD controls. The majority of patients with CD positive for pANCA had a UC-like presentation. Disease location, duration, activity, complications, and treatment with immunosuppressive drugs did not have an impact on the ASCA or pANCA assay results. After resection, UC patients remained pANCA positive, in contrast to patients with CD, in whom ASCA titers decreased toward normal values postoperatively.
Conclusions:
ASCA and pANCA assays are highly disease specific for CD and UC, respectively. These serological tests can assist clinicians in diagnosing and categorizing patients with IBD and may be useful in making therapeutic decisions.
